title: Recombinant LPG3 Stimulates IFN-Γ and TNF-A Secretion by Human NK Cells.
abstract: BACKGROUND
  Natural killer (NK) cells play an important role in early stages of innate immune responses against viral and tumoral attacks. Activation of NK cells by leishmaniasis results in secretion of cytokines such as interferon (IFN)-γ and tumor necrosis factor (TNF)-α, which enhances the phagocytosis and clearance of parasite. Lipophosphoglycan 3 (LPG3), the Leishmania homologous with GRP94 (glucose regulated protein 94), a member of HSP90 family, contributes to LPG assembly as the most abundant macromolecule on the surface of Leishmania promastigotes.
  
  
  METHODS
  We purified NK cells from healthy individuals (n=10) using magnetic-activated cell sorting (MACS) technology. Purified NK cells were co-incubated with different concentrations of recombinant LPG3 (rLPG3), and its N-terminal (NT) and C-terminal (CT) fragments. Finally, the production of IFN-γ and TNF-α by NK cells were measured by ELISA.
  
  
  RESULTS
  Recombinant LPG3 but not its fragments (CT and NT), can significantly enhance the production of TNF-α by NK cells (P<0.05). Moreover, rLPG3, CT, and NT fragments were markedly stimulated the secretion of IFN-γ by NK cells (P<0.001).
  
  
  CONCLUSIONS
  The Leishmania LPG3 antigen can effectively activate NK cells, in vitro. Leishmania LPG3 participates in the innate immunity against leishmaniasis and thereby improves the effective parasite destruction. However, its efficiency should be tested in vivo.
authors.affiliation: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Sanaz
authors.initials: S
authors.lastname: Rasolzadeh
authors.affiliation: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Mostafa
authors.initials: M
authors.lastname: Haji Fatahaliha
authors.affiliation: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Maryam
authors.initials: M
authors.lastname: Hosseini
authors.affiliation: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Reza
authors.initials: R
authors.lastname: Jafari
authors.affiliation: Dept. of Medical Parasitology and Mycology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
authors.forename: Abolfazl
authors.initials: A
authors.lastname: Miahipour
authors.affiliation: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Ali Akbar
authors.initials: AA
authors.lastname: Movassaghpour
authors.affiliation: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Zohreh
authors.initials: Z
authors.lastname: Babalo
authors.affiliation: Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran.
authors.forename: Sima
authors.initials: S
authors.lastname: Rafati
authors.affiliation: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Dept. of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Mehdi
authors.initials: M
authors.lastname: Yousefi
keywords: LPG3; Leishmania; Natural killer cell; TLR
references.citation: Eur J Immunol. 1995 Aug;25(8):2401-7
references.pmid: 7664802
references.citation: Curr Opin Immunol. 2000 Feb;12(1):64-76
references.pmid: 10679404
references.citation: Lancet Infect Dis. 2007 Sep;7(9):581-96
references.pmid: 17714672
references.citation: Trends Parasitol. 2005 Nov;21(11):508-12
references.pmid: 16150644
references.citation: J Immunol. 1990 Dec 15;145(12):4306-10
references.pmid: 2175327
references.citation: Immunology. 1990 Apr;69(4):570-3
references.pmid: 2335376
references.citation: Curr Opin Immunol. 1995 Feb;7(1):34-40
references.pmid: 7772279
references.citation: Annu Rev Immunol. 1995;13:151-77
references.pmid: 7612219
references.citation: Immunol Today. 2000 Jun;21(6):254-6
references.pmid: 10825735
references.citation: Infect Immun. 1991 Aug;59(8):2839-42
references.pmid: 1906844
references.citation: PLoS One. 2014 Oct 13;9(10):e108848
references.pmid: 25310094
references.citation: EMBO J. 2000 May 2;19(9):1953-62
references.pmid: 10790362
references.citation: Infect Immun. 1999 Jun;67(6):3155-9
references.pmid: 10338536
references.citation: J Parasitol Res. 2012;2012:165126
references.pmid: 22523640
references.citation: Trop Med Int Health. 1999 Dec;4(12):801-11
references.pmid: 10632987
references.citation: J Exp Med. 1995 Mar 1;181(3):961-71
references.pmid: 7869054
references.citation: Front Immunol. 2014 Aug 22;5:380
references.pmid: 25202307
references.citation: Immunobiology. 2008;213(3-4):377-87
references.pmid: 18406382
references.citation: Eur J Immunol. 1995 Aug;25(8):2220-7
references.pmid: 7664785
references.citation: Trends Microbiol. 1998 Jan;6(1):35-40
references.pmid: 9481823
references.citation: PLoS One. 2012;7(5):e35671
references.pmid: 22693548
references.citation: Exp Parasitol. 2011 Mar;127(3):627-36
references.pmid: 21187087
references.citation: Parasite Immunol. 2014 Dec;36(12):700-7
references.pmid: 25244583
references.citation: Mem Inst Oswaldo Cruz. 2007 Feb;102(1):79-82
references.pmid: 17294004
references.citation: Infect Immun. 1994 Apr;62(4):1414-20
references.pmid: 8132347
references.citation: Eur J Immunol. 1990 May;20(5):1131-5
references.pmid: 2113475
references.citation: EMBO J. 2002 Sep 2;21(17):4458-69
references.pmid: 12198148
references.citation: Immunol Rev. 2000 Feb;173:17-26
references.pmid: 10719664
references.citation: Biochem J. 1995 Sep 15;310 ( Pt 3):807-18
references.pmid: 7575413
references.citation: Infect Immun. 1998 Jun;66(6):2698-704
references.pmid: 9596736
references.citation: J Exp Med. 2000 Apr 17;191(8):1259-62
references.pmid: 10770793
references.citation: Immunol Today. 2000 Sep;21(9):420-2
references.pmid: 10953091
references.citation: Clin Exp Immunol. 1993 Dec;94(3):516-21
references.pmid: 7902789